Inotiv, Inc. — Director's Dealing 2018

Sep 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2018-09-14

Reporting Person: KISSINGER PETER (10% Owner)
Reporting Person: KISSINGER CANDICE B (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-14	Common Stock	P	10000	$1.7382	Acquired	1033457	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	848220	Direct

Footnotes

F1: Represents the purchase of 10,000 shares in multiple transactions ranging in price from $1.68 to $1.78 per share, resulting in a weighted average purchase price of $1.7382. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

F2: Shares were purchased by Peter T. Kissinger individually; direct holdings of Peter T. Kissinger after this transaction include 595,910 shares held jointly with Candice B. Kissinger. Shares that are reported as individually held by Candice B. Kissinger or held jointly by Candice B. Kissinger and her children are deemed to be indirectly held by Peter T. Kissinger.

F3: The total amount of shares beneficially owned by Peter T. Kissinger reflects the sale of 200 shares held by Peter T. Kissinger individually on March 7, 2008, which was inadvertently omitted from the Form 4 filed by Peter T. Kissinger on March 10, 2008.

F4: Shares held directly by Candice B. Kissinger; includes 595,910 shares held jointly by Peter T. Kissinger and Candice B. Kissinger and 1,354 shares held jointly by Candice B. Kissinger and her children. Shares that are reported as individually held by Peter T. Kissinger are deemed to be indirectly held by Candice B. Kissinger.